Our Advanced Medical Solutions Sector is engaged in leading-edge medicines CDMO (Contract Development and Manufacturing Organization) business, including long-chain oligonucleotides, and small molecule drugs. We are also engaged in the manufacture and sale of RI diagnostic agents and research and development of regenerative medicine and cell therapies. Through these solutions and products, we aim to meet a diverse range of medical and healthcare needs, contributing to healthier and more fulfilling lives.

Pharmaceutical Chemicals

We engage in the manufacture and sale of APIs and intermediates outsourced from pharmaceutical companies, as well as pharmaceutical chemical products developed in-house, such as generic APIs, based on our advanced organic synthesis technologies and quality assurance capabilities. Nucleic acid medicines are next-generation pharmaceuticals, utilizing functions of oligonucleotides which act on genes and proteins that cause disease. We also undertake contract manufacturing for oligonucleotide APIs for pharmaceutical companies.

To explore our offerings, please contact our Group Company:

Sumitomo Chemical
Website